天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Home Cart 0 Sign in  

[ CAS No. 52-90-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 52-90-4
Chemical Structure| 52-90-4
Structure of 52-90-4 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 52-90-4 ]

Related Doc. of [ 52-90-4 ]

Alternatived Products of [ 52-90-4 ]
Product Citations

Product Citations      Expand+

Faisal Aziz ; Kanamata Reddy ; Virneliz Fernandez Vega , et al. DOI:

Abstract: The suppressor of T cell receptor signaling (Sts) proteins are negative regulators of immune signaling. Genetic inactivation of these proteins leads to significant resistance to infection. From a 590,000 compound high-throughput screen, we identified the 2-(1H)-quinolinone derivative, , as a putative inhibitor of Sts activity. , and a small library of derivatives, are competitive, selective inhibitors of Sts-1 with IC50 values from low to submicromolar. SAR analysis indicates that the , the acid, and the moieties are all essential for activity. A crystal structure confirmed the SAR and reveals key interactions between this class of compound and the . Although has poor cell permeability, we demonstrated that a liposomal preparation can inactivate the activity of Sts-1 in cells. These studies demonstrate that Sts-1 enzyme activity can be pharmacologically inactivated and provide foundational tools and insights for the development of immune-enhancing therapies that target the Sts proteins.

Purchased from AmBeed: ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;

Wu, Jiandong ; Chernatynskaya, Anna ; Pfaff, Annalise , et al. DOI: PubMed ID:

Abstract: Oxidative stress may contribute to the pathol. of many diseases, and endogenous thiols, especially glutathione (GSH) and its metabolites, play essential roles in the maintenance of normal redox status. Understanding how these metabolites change in response to oxidative insult can provide key insights into potential methods of prevention and treatment. Most existing methodologies focus only on the GSH/GSH disulfide (GSSG) redox couple, but GSH regulation is highly complex and depends on several pathways with multiple redox-active sulfur-containing species. In order to more fully characterize thiol redox status in response to oxidative insult, a high-performance liquid chromatog. with tandem mass spectrometry (HPLC-MS/MS) method was developed to simultaneously determine seven sulfur-containing metabolites, generating a panel that systematically examines several pathways involved in thiol metabolism and oxidative stress responses. The sensitivity (LOQ as low as 0.01 ng/mL), accuracy (88-126% spike recovery), and precision (=12% RSD) were comparable or superior to those of existing methods. Addnl., the method was used to compare the baseline thiol profiles and oxidative stress responses of cell lines derived from different tissues. The results revealed a previously unreported response to oxidative stress in lens epithelial (B3) cells, which may be exploited as a new therapeutic target for oxidative-stress-related ocular diseases. Further application of this method may uncover new pathways involved in oxidative-stress-related diseases and endogenous defense mechanisms.

Keywords: HPLC-MS/MS ; biomarker ; cancer cells ; glutathione ; lens epithelial cells ; thiol

Purchased from AmBeed: 52-90-4

Wu, Jiandong ; Sigler, Austin ; Pfaff, Annalise , et al. DOI: PubMed ID:

Abstract: Oxidative stress is reported to be part of the pathol. of many ocular diseases. For the diagnosis of ocular diseases, tear fluid has unique advantages. Although numerous anal. methods exist for the measurement of different types of biomols. in tear fluid, few have been reported for comprehensive understanding of oxidative stress-related thiol redox signaling. In this study, a high-performance liquid chromatog.-tandem mass spectrometry (HPLC-MS/MS) method was developed to determine a panel of twelve metabolites that systematically covered several thiol metabolic pathways. With optimization of MS/MS parameters and HPLC mobile phases, this method was sensitive (LOQ as low as 0.01 ng/mL), accurate (80-125% spike recovery) and precise (<10% RSD). This LC-MS/MS method combined with a simple tear fluid collection with Schirmer test strip followed by ultrafiltration allowed the high-throughput anal. for efficient determination of metabolites associated with thiol redox signaling in human tear fluids. The method was then applied to a small cohort of tear fluids obtained from healthy individuals. The method presented here provides a new technique to facilitate future work aiming to determine the complex thiol redox signaling in tear fluids for accurate assessment and diagnosis of ocular diseases.

Keywords: Biomarker ; Glutathione ; HPLC-MS/MS ; Ocular disease ; Tear fluid ; Thiol

Purchased from AmBeed: ;

Product Details of [ 52-90-4 ]

CAS No. :52-90-4 MDL No. :MFCD00064306
Formula : C3H7NO2S Boiling Point : -
Linear Structure Formula :H2NCH(CH2SH)CO2H InChI Key :XUJNEKJLAYXESH-REOHCLBHSA-N
M.W : 121.16 Pubchem ID :5862
Synonyms :
Cysteine;L-Cys;Cysteinum;FEMA No. 3263;NSC 8746;(R)-Cysteine;L-(+)-Cysteine
Chemical Name :(R)-2-Amino-3-mercaptopropanoic acid

Calculated chemistry of [ 52-90-4 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 7
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.67
Num. rotatable bonds : 2
Num. H-bond acceptors : 3.0
Num. H-bond donors : 2.0
Molar Refractivity : 28.94
TPSA : 102.12 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -8.81 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.37
Log Po/w (XLOGP3) : -2.49
Log Po/w (WLOGP) : -0.67
Log Po/w (MLOGP) : -3.06
Log Po/w (SILICOS-IT) : -0.69
Consensus Log Po/w : -1.31

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 3.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : 1.11
Solubility : 1560.0 mg/ml ; 12.9 mol/l
Class : Highly soluble
Log S (Ali) : 0.89
Solubility : 936.0 mg/ml ; 7.73 mol/l
Class : Highly soluble
Log S (SILICOS-IT) : 0.59
Solubility : 470.0 mg/ml ; 3.88 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.75

Safety of [ 52-90-4 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P501-P270-P264-P301+P312+P330 UN#:N/A
Hazard Statements:H302 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 52-90-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 52-90-4 ]
  • Downstream synthetic route of [ 52-90-4 ]

[ 52-90-4 ] Synthesis Path-Upstream   1~7

  • 1
  • [ 52-90-4 ]
  • [ 1483-72-3 ]
  • [ 34317-61-8 ]
Reference: [1] Journal of the American Chemical Society, 1947, vol. 69, p. 1550
  • 2
  • [ 52-90-4 ]
  • [ 34317-61-8 ]
Reference: [1] Biochemical Journal, 1951, vol. 48, p. 624,625
  • 3
  • [ 2684-02-8 ]
  • [ 52-90-4 ]
  • [ 34317-61-8 ]
Reference: [1] Journal of Biological Chemistry, 1943, vol. 151, p. 211,212
[2] Journal of Biological Chemistry, 1931, vol. 94, p. 541,544
[3] Journal of Biological Chemistry, 1931, vol. 94, p. 541,544
  • 4
  • [ 52-90-4 ]
  • [ 1483-72-3 ]
  • [ 7732-18-5 ]
  • [ 34317-61-8 ]
Reference: [1] Journal of the American Chemical Society, 1947, vol. 69, p. 1550
  • 5
  • [ 52-90-4 ]
  • [ 32315-10-9 ]
  • [ 19771-63-2 ]
Reference: [1] Synthetic Communications, 1993, vol. 23, # 20, p. 2839 - 2844
[2] Patent: US10239847, 2019, B1, . Location in patent: Page/Page column 9; 10
  • 6
  • [ 75-44-5 ]
  • [ 52-90-4 ]
  • [ 19771-63-2 ]
Reference: [1] Bulletin of the Chemical Society of Japan, 1964, vol. 37, # 2, p. 242 - 244
  • 7
  • [ 52-90-4 ]
  • [ 19771-63-2 ]
Reference: [1] Patent: EP1462444, 2004, A1, . Location in patent: Page 12
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Similar Product of
[ 52-90-4 ]

Chemical Structure| 204523-09-1

A1175681[ 204523-09-1 ]

L-cysteine-15N

Reason: Stable Isotope

Chemical Structure| 202406-97-1

A1230106[ 202406-97-1 ]

L-Cysteine-13C3,15N

Reason: Stable Isotope

Chemical Structure| 202114-66-7

A1267982[ 202114-66-7 ]

L-Cysteine-13C3

Reason: Stable Isotope

Chemical Structure| 224054-24-4

A1267670[ 224054-24-4 ]

L-CYSTEINE (1-13C)

Reason: Stable Isotope

Chemical Structure| 201612-57-9

A1502788[ 201612-57-9 ]

L-Cysteine-3-13C

Reason: Stable Isotope

; ;